ENTITY

Insulet Corp (PODD US)

87
Analysis
Health CareUnited States
Insulet Corporation is a medical device company that develops, manufactures and markets an insulin infusion system for people with insulin-dependent diabetes.
more
bullishEoflow
05 Oct 2023 20:25

Eoflow: Ozempic and Wegovy Reducing Need for Disposable Insulin Injection Devices + Ongoing Lawsuit?

Eoflow's share price has dropped 27% lower than the proposed tender offer price of 30,000 won. In this insight, we discuss two major factors have...

Logo
1.2k Views
Share
bullishNws Holdings
02 Oct 2023 00:13

Merger Arb Mondays (02 Oct) - NWS, Mason, IMAX China, Keiyo, System Info, Toyo, Symbio, Allkem

This week, the highest gross spreads are Keiyo (58.3%), 111 (40.8%), Eoflow (22.4%), Symbio (19.3%), IMAX China (19.0%), JSR (8.3%), Boustead...

Logo
3.9k Views
Share
bullishENM Holdings
25 Sep 2023 00:21

Merger Arb Mondays (25 Sep) - ENM, Poly Culture, Eoflow, Origin Energy, Symbio, Costa, InvoCare

This week, the highest gross spreads are 111 (48.9%), Eoflow (23.7%), Symbio (10.7%), Mason Group (9.0%), JSR (7.8%), DDH1 (6.0%), ENM (5.5%),...

Logo
632 Views
Share
21 Sep 2023 16:49

Tandem Diabetes Care (TNDM US): Q2 Sales Declined, Margin Deteriorated; 2023 Guidance Revised Lower

​Tandem's Q2 sales declined 2% YoY to $195.9M, as global pump shipment plummeted 8% YoY to 29,494. The company has lowered 2023 sales guidance to...

Logo
454 Views
Share
bullishInsulet Corp
15 Sep 2023 14:00

Insulet Corporation: Launch of Omnipod 5 & Other Major Developments

Insulet Corporation exceeded analyst expectations in terms of revenue as well as earnings. The company's revenue for the second quarter surpassed...

Logo
412 Views
Share
x